*Coverage data provided are for individuals aged ≥12 years, based on the current approved indication for COMIRNATY. Some plans may not display due to health plan–specific policy. Results displayed are variable based on the data available for the zip code entered. Calculations are based on the Core Based Statistical Area (CBSA) of that zip code. If the zip code does not align to a CBSA, state level coverage will be reflected.
†Commercial includes Health Exchange.
‡Access is defined as covered or not covered.
§Medicaid includes Managed and State Medicaid.

The information provided is not a guarantee of coverage of payment (partial or full) and is subject to change without notice.

Source: Managed Markets Insight & Technology, LLC, Database as of [July 2025.]

Patients in your area have access to EUCRISA without restriction or after a trial of one plan-designated topical corticosteroid^†

UR – Unrestricted, PA – Prior Authorization, SE – Step Edit/Step Therapy

*Access is defined as no formulary restrictions or trial of one plan-designated topical corticosteroid (TCS).

Not a guarantee of coverage and subject to change. Patients can learn more about their coverage by contacting eucrisa•4•you, their employer, health plan, pharmacy benefits manager(PBM), or retail pharmacy.

^†This information relates solely to the formulary status of Eucrisa and is not intended to imply that these products have comparable clincial efficacy or safety profiles or that these products are interchangable. These agents may not have comparable FDA-approved indications.

[LEVEL_MESSAGE]

May not be a comprehensive list of plans.

Data on file. Pfizer Inc., New York, NY.

^†Additional plan limitations may apply relevant to a look back period of time or duration of TCS use.